Heran Partners

Founded in 2020, Heran Partners is a Belgian venture capital firm focused on investing in healthcare technology, medical technology, deep tech, and digital health sectors. The firm provides venture and growth capital alongside expertise, mentorship, and network support to European HealthTech startups and scale-ups with strong technology platforms and market potential.

Katleen Vandersmissen

Managing Partner

Geoffrey D'hondt

Investment Director

7 past transactions

Nuclivision

Seed Round in 2025
Nuclivision develops innovative radiotracers and treatments for oncology, utilizing AI-driven solutions to enhance the quality, safety, and accessibility of nuclear medicine. Its platform improves efficiency in image acquisition and diagnosis, enabling doctors to scan more patients daily at reduced costs.

Broken String Biosciences

Series A in 2023
Broken String Biosciences is focused on developing a novel sequencing platform aimed at assessing genome stability to enhance the safety and efficacy of cell and gene therapies. By integrating advanced sequencing techniques with bioinformatics analysis and artificial intelligence, the company provides healthcare professionals with a comprehensive, data-driven approach to medicine. This innovative platform is designed to facilitate the development of the next generation of therapies, ensuring they are safer by design and capable of addressing various medical challenges. Through its efforts, Broken String Biosciences aims to unlock new possibilities in the realm of advanced therapeutic solutions.

Thirona

Series B in 2023
Thirona is a software company that develops AI-powered medical imaging analysis tools and provides image analysis services for the healthcare industry. Its automated tools support the analysis of thoracic CT scans, chest X-rays, and retinal images, delivering accurate and repeatable measurements to help hospitals detect and mitigate diseases. The company offers software solutions and certified image analysis services that streamline imaging workflows and improve diagnostic precision.

Hypervision Surgical

Seed Round in 2023
Hypervision Surgical develops an AI-powered hyperspectral imaging platform designed to enhance surgical precision, safety, and speed. The non-contact, non-invasive optical system splits light into multiple spectral bands to provide real-time, data-driven tissue characterization that can be visualized intraoperatively without contrast agents. This approach enables clinicians to assess tissue during procedures, potentially improving accuracy, reducing risk, and supporting decision-making throughout surgery.

LynxCare

Series A in 2022
LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-powered data platform that collects, analyzes, and interprets both structured and unstructured data from diverse sources. This platform, designed for hospitals and clinics, empowers medical professionals with actionable insights, enabling them to enhance clinical efficiency and improve the quality of patient care.

Thirona

Venture Round in 2021
Thirona is a software company that develops AI-powered medical imaging analysis tools and provides image analysis services for the healthcare industry. Its automated tools support the analysis of thoracic CT scans, chest X-rays, and retinal images, delivering accurate and repeatable measurements to help hospitals detect and mitigate diseases. The company offers software solutions and certified image analysis services that streamline imaging workflows and improve diagnostic precision.

LynxCare

Venture Round in 2020
LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-powered data platform that collects, analyzes, and interprets both structured and unstructured data from diverse sources. This platform, designed for hospitals and clinics, empowers medical professionals with actionable insights, enabling them to enhance clinical efficiency and improve the quality of patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.